PAI
ProQuest Associates IV Portfolio holdings
AUM
$53M
This Quarter Return
+76.09%
1 Year Return
+3.35%
3 Year Return
+116.54%
5 Year Return
–
10 Year Return
–
AUM
$487M
AUM Growth
+$487M
(+59%)
Cap. Flow
-$8.88M
Cap. Flow
% of AUM
-1.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
IMDZ
Immune Design Corp.
IMDZ
|
$8.88M |
| 2 |
AGRX
Agile Therapeutics, Inc
AGRX
|
$859 |
Sector Composition
| 1 | Healthcare | 83.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $387M | 79.39% | 4,780,188 | – | – |
|
|
IMDZ
2
DELISTED
Immune Design Corp.
IMDZ
| $41M | 8.41% | 1,983,858 -430,182 | -18% | -$8.88M |
|
|
AGRX
3
DELISTED
Agile Therapeutics, Inc
AGRX
| $40.1M | 8.24% | 4,668,663 -100 | -0% | -$859 |
|
|
ANTH
4
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $16.4M | 3.36% | 1,900,000 | – | – |
|
|
ZSAN
5
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.67M | 0.34% | 229,759 | – | – |
|
6
Savara
SVRA
$567M
| $1.25M | 0.26% | 2,551,851 | – | – |
|